GenRx Cabergoline cabergoline 500 micrograms tablets bottle

País: Australia

Idioma: inglés

Fuente: Department of Health (Therapeutic Goods Administration)

Ingredientes activos:

cabergoline, Quantity: 500 microgram

Disponible desde:

Arrotex Pharmaceuticals Pty Ltd

Designación común internacional (DCI):

Cabergoline

formulario farmacéutico:

Tablet

Composición:

Excipient Ingredients: lactose; magnesium stearate

Vía de administración:

Oral

Unidades en paquete:

8 tablets, 2 tablets

tipo de receta:

(S4) Prescription Only Medicine

indicaciones terapéuticas:

? Inhibition of physiological lactation ,Cabergoline is indicated for the prevention of the onset of physiological lactation in the puerperium for clearly defined medical reasons. ,? Treatment of hyperprolactinaemic disorders ,Cabergoline is indicated for the treatment of pathological hyperprolactinaemia.

Resumen del producto:

Visual Identification: White coloured, capsule shaped, flat, scored tablets with debossed "APO" on one side and "CA" bisect "0.5" on the other side.; Container Type: Bottle; Container Material: Glass Type III Coloured; Container Life Time: 21 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Child resistant closure

Estado de Autorización:

Licence status A

Fecha de autorización:

2015-11-20